Effect of delayed-release dimethyl fumarate on no evident disease activity in newly diagnosed relapsing-remitting multiple sclerosis patients: An integrated analysis of the phase 3 DEFINE and CONFIRM studies

Authors
Category Primary study
JournalNeurology
Year 2015
This article has no abstract
Epistemonikos ID: 40ec1d6cbf67822cac5789fb87d4d3c77039d679
First added on: Feb 07, 2025